Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CALC - CalciMedica Inc

IEX Last Trade
4.07
-0.230   -5.651%

Share volume: 8,559
Last Updated: Fri 30 Aug 2024 08:50:13 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$4.30
-0.23
-5.35%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
3.96%
1 Month
-18.87%
3 Months
-26.46%
6 Months
-4.49%
1 Year
38.07%
2 Year
-97.90%
Key data
Stock price
$4.07
P/E Ratio 
0.00
DAY RANGE
$4.07 - N/A
EPS 
$0.00
52 WEEK RANGE
$1.75 - $8.38
52 WEEK CHANGE
$0.30
MARKET CAP 
44.828 M
YIELD 
N/A
SHARES OUTSTANDING 
10.750 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$38,030
AVERAGE 30 VOLUME 
$21,901
Company detail
CEO:
Region: US
Website:
Employees: 13
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

calcimedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of autoimmune disorders, organ transplant rejection, and other immune diseases.

Recent news